Adjuvant Capital Management, LLC, 10% Owner at AN2 Therapeutics, Inc. (ANTX), sold 200,000 shares at $19.65 ($3.9M) on 2024-01-16, disclosed to the SEC on 2024-01-18.
Open-market sale of $3.9M ANTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.65 | 15,907 | $313K | 8.0% |
| 2 | $19.65 | 15,907 | $313K | 8.0% |
| 3 | $19.65 | 84,093 | $1.7M | 42.0% |
| 4 | $19.65 | 84,093 | $1.7M | 42.0% |
| Total | $19.65 avg | 200,000 | $3.9M | 100% |